Literature DB >> 1523881

Parameters affecting the immunogenicity of microencapsulated tetanus toxoid.

I Esparza1, T Kissel.   

Abstract

The immunogenic potential of tetanus toxoid (TT) was compared when either adsorbed to aluminium hydroxide (TT-alum) or entrapped in microparticles consisting of poly(D,L-lactic-co-glycolic acid) (PLA:PGA, 55:45) derived polymers. Furthermore, the effect of administering the microparticles in an aqueous buffer or water-in-oil emulsion on the TT immunogenicity was also investigated. When mice were immunized with the different formulations, similar levels of anti-TT antibodies were observed during the primary IgG response. The choice of the carrier seemed to play an important role for both the level and maintenance of the secondary IgG response, attained as a consequence of a booster immunization with TT-alum. The strongest secondary antibody response was obtained by priming with TT-containing microparticles, resuspended in water-in-oil emulsions. As expected, incomplete Freund's adjuvant (IFA) proved to be a more potent adjuvant than peanut oil, whereas resuspension of the microparticles in aqueous solution induced a relatively less efficient antibody response. Overall, microencapsulated TT primed the mice more effectively, since the secondary antibody response was higher and persisted longer compared with TT-alum priming. These results indicate that in addition to TT maintaining its antigenicity after microencapsulation, the microparticles also potentiate its immunogenic properties. This approach should prove very useful for designing more effective vaccines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523881     DOI: 10.1016/0264-410x(92)90094-z

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

2.  Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

Authors:  P Johansen; Y Men; R Audran; G Corradin; H P Merkle; B Gander
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.

Authors:  M Tobío; J Nolley; Y Guo; J McIver; M J Alonso
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

4.  Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.

Authors:  S P Schwendeman; H R Costantino; R K Gupta; G R Siber; A M Klibanov; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Adjuvant dependence of APS pathology-related low-affinity antibodies during secondary immune response to tetanus toxoid in BALB/c mice.

Authors:  Irena Zivković; Vladimir Petrušić; Rajna Dimitrijević; Marijana Stojanović; Ljiljana Dimitrijević
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

6.  Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.

Authors:  D H Jones; B W McBride; C Thornton; D T O'Hagan; A Robinson; G H Farrar
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

7.  Determinants of release rate of tetanus vaccine from polyester microspheres.

Authors:  M J Alonso; S Cohen; T G Park; R K Gupta; G R Siber; R Langer
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

8.  Gamma irradiation of active self-healing PLGA microspheres for efficient aqueous encapsulation of vaccine antigens.

Authors:  Kashappa-Goud H Desai; Samer Kadous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2013-03-21       Impact factor: 4.200

Review 9.  Needle-Free Immunization with Chitosan-Based Systems.

Authors:  Bijay Singh; Sushila Maharjan; Princy Sindurakar; Ki-Hyun Cho; Yun-Jaie Choi; Chong-Su Cho
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

Review 10.  Novel adjuvants & delivery vehicles for vaccines development: a road ahead.

Authors:  Teena Mohan; Priyanka Verma; D Nageswara Rao
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.